JointHealth™ express January 21, 2008
Several members of the ACE team are in Ottawa today, holding a press conference to highlight the inequities in care faced by people with arthritis across the country.
As ACE revealed last year with the publication of our report card on biologic response modifier coverage, Canadians with arthritis face significant inequities in access to treatment. These inequities are based on several factors, including disease type, financial status, and province of residence.
Click here to read more about this national press conference, including our updated report card and press release.
Several members of the ACE team are in Ottawa today, holding a press conference to highlight the inequities in care faced by people with arthritis across the country.
As ACE revealed last year with the publication of our report card on biologic response modifier coverage, Canadians with arthritis face significant inequities in access to treatment. These inequities are based on several factors, including disease type, financial status, and province of residence.
Click here to read more about this national press conference, including our updated report card and press release.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.